Project Details
Description
ABSTRACT
The goal of this project is to study the role of the host sphingosine kinase 1 (SK1) pathway in controlling infection by the
fungus Cryptococcus neoformans (Cn) during immunodeficiency. A mouse model of lung cryptococcal granuloma that
recapitulates the human granuloma was developed. When these mice become immunocompromised, the fungus
disseminates to the brain, causing meningo-encephalitis.1 Thus, our mouse model mimics the physiopathology of the infection
in immunocompromised subjects with which cryptococcosis is mostly associated.2
In recent years, patients treated with FTY720 (Fingolimod) for multiple sclerosis3 (MS) have developed cryptococcosis.4-9
Studies using the animal model in the lab showed that host sphingosine kinase 1 (SK1) and its product sphingosine-1-
phosphate (S1P) are critical for the formation of the lung granuloma against Cn.1, 10, 11 In addition, treatment with FTY720
reactivated Cn infection from the lung granuloma, and fungal cells that disseminate to the brain cause lethal meningo-
encephalitis.12 This reactivation does not occur when mice were treated with BAF312 or AUY954, which are also used to
treat MS patients by targeting sphingosine-1-phosphate receptors (S1Prs). FTY720 is a sphingosine analog that, once
phosphorylated, mimics S1P and binds to S1P receptors S1Pr1, S1Pr3 and S1Pr513 whereas BAF312 or AUY954 binds to
S1Pr1 and S1Pr5,14 or only to S1Pr1,15 respectively. These results suggest that SK1-S1P may regulate the containment of
Cn cells within the lung granuloma through the activation of a specific S1P receptor(s), such as S1Pr3, as this is one of the
receptors blocked by FTY720 but not by the other compounds. Treatment with FTY720, but not with BAF312, was associated
with disorganization of macrophages and with M2 polarization at the granuloma site.12 In a cell system, Cn cells are poorly
internalized or killed by macrophages lacking S1Pr3. Very interestingly, both internalization and killing by macrophages can
be inhibited by S1Pr3 antagonists and enhanced by S1Pr3 agonists.12
Based on these findings, the hypothesis is that the S1P-S1Pr pathway regulates the host cellular immunity against
Cn at the granuloma and that antagonizing S1Pr3 is detrimental for the host and may lead to reactivation of
cryptococcosis during lymphopenia. Thus, the following aims are proposed: 1) Determine the immune mechanism by
which of SK1-S1P regulates the organization of Cn granuloma; and 2) Define the immune response by which by
SK1-S1P protects from Cn reactivation.
| Status | Active |
|---|---|
| Effective start/end date | 02/1/25 → 01/31/27 |
Funding
- National Institute of Allergy & Infectious Disease: $3,840,706.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.